HELPING DETECT AND MANAGE
Since the 1980s, the Gastrolyzer® range breath hydrogen (H2) and methane (CH4) monitors have been the gold standard to aid in the detection and management of gastrointestinal disorders.
One monitor can do it all :
- SIBO (small intestinal bacterial overgrowth)
- Intolerances & Malabsorption Issues:
- Lactose Intolerance
- Fructose Intolerance
- Fructan Intolerance
- Sucrose Intolerance
- Sorbitol Intolerance
- Xylitol Intolerance
Family of Breath H2 & CH4 Monitors
The world’s most advanced CH4 & H2 monitor gets even better with:
● instant warm up
● 2 Sampling Modes: direct via
mouthpiece or take home test kits
● & more…
The world’s most advanced handheld H2 monitor gets even better with:
● instant warm up
● ability to manage multiple studies
on the monitor
● & more…
The features that matter for office efficiency and patient comfort.
Benefits to Practice & Patients
Benefits to Practice
- Low cost of study supplies
- Reimbursable by insurance, average reimbursement $85.00
- Maximize reimbursement by keeping testing in office
- Simple to use by staff
- Lowest maintenance compared to other devices on the market ● Instant results – no need to send out of office, save money, and save time
- Flexible sampling options: Direct sampling or take home test kits (GastroCHECK only)
- Interacts with GastroCHART™ patient management and database software – works with timers to assist with work-flow, manage studies and maximize reimbursement (up to 10 patients simultaneously)
Benefits to Patient
- Non-invasive test for fast and accurate diagnosis and relief
- Safe and simple test to perform – not physically strenuous – only requires patients to breathe
- Covered by most insurance carriers
- Simple prep – no need to drink a nasty tasting solution that will “clean you out”
- Patient can go back to work after the test instead of taking a full sick day
- Test managed by patient’s local Gastro office ensures faster & more reliable results
- HBT test offers a starting point to craft a diet to assist in avoiding problematic foods
Why of Breath CH4 & H2 test?
Ability to Detect & Manage Multiple Disorders
INSTANT DETECTION | MANAGE DISORDERS
Hydrogen Breath Testing (HBT)
HBT is a non-invasive, and specific means of diagnosing small bowel sugar malabsorption. HBT makes use of gut bacteria’s ability to digest sugars and convert these to hydrogen & methane , which is then absorbed into the blood and can be measured in exhaled breath1.
The test is commonly used in adult and pediatric gastroenterology departments to diagnose malabsorption of the sugars lactose, fructose and sucrose etc. It is also used to investigate small intestinal bacterial overgrowth (SIBO)2. The Gastrolyzer® range is world renowned for delivering accurate hydrogen & methane breath testing, cited by clinical leaders in gastroenterology, such as Robert Heuschkel3 and Way Seah Lee4
Ability to Detect & Manage Multiple Disorders
- Intolerances & Malabsorption: lactose, fructose, sorbitol, sucrose, fructan, xylitol, etc.
- Average $85 – CPT Code: 91065 – Breath hydrogen/methane test (eg, for detection of lactase deficiency, fructose intolerance, bacterial overgrowth, or oro-cecal gastrointestinal transit)
Low Cost & Maintenance
- Inexpensive consumables
- Simple maintenance
Anyone Can Administer the Test
- Anyone can administer the test with no special licensure required. Breath testing is not regulated under C.L.I.A.
- Works on a breath sample, no bodily fluids or medications required for test
- The monitor provides instant results shown in parts per million (ppm) of Methane (CH4) & Hydrogen (H2) which makes interpreting patient’s results quick and easy. No waiting for results from lab.
Accurate & Reliable
- 40+ year hydrogen breath test (HBT) heritage, shows it is reliable analytical method
- Relied on by hospitals & research institutions for over 4 decades
Simple Test for Patients
- Patients can return to work the same day
- No special medication required to perform test
Why is it important?
The Gastrolyzer® hydrogen and methane breath test is a non-invasive way to help doctors diagnose and manage a number of conditions and disorders. One such condition the Gastrolyzer® tests for is lactose intolerance. Nearly 70% of the global population is intolerant to lactose. In the United States alone thirty to fifty million Americans are lactose intolerant. Additionally, the Gastrolyzer® can test for all these intolerances and malabsorption issues: fructose, sorbitol, sucrose, fructan, xylitol, & more. As well as testing for Small Intestinal Bacterial Overgrowth (SIBO).
About 30% of the world’s population are methane producers. These people produce methane because they have a specific species of archaea (a different type of organism from bacteria) in their gut called Methanobrevibacter Smithii that feeds on hydrogen produced in the gut which is then turned into methane, which is released into the gut and ultimately out into the breath. It takes 4 molecules of hydrogen to make 1 molecule of methane, which is why the methane breath measurement will typically be less than that of hydrogen, but has the same diagnostic implications. It is important to test for methane as well as hydrogen because people can have symptoms from the methane that is released into their gut, but it would go undetected if only hydrogen is measured. Methane slows down transit time by slowing the peristalsis reflex, which is the muscle that moves food along the digestive tract. Constipation is the most common clinical symptom of a methane producer. It has been found that there is a direct correlation between the amount of Methanobrevibacter Smithii in the gut, the amount of methane released in the breath, and the severity of the constipation.
Gastrolyzer® breath testing is inexpensive, non-invasive, and is a revenue stream for the practice. Plus, the test is easy on the patient, efficient, and is covered by most insurance carriers.
And since the results are immediate, the breath test allows doctors to arrive at a diagnosis quickly and accurately and allows patient to have better quality of life and gut health.
Hydrogen Breath Testing (HBT) is typically offered to patients reporting or with indications of the following clinical complaints or disorders (regardless of when these complaints occur):
Indications of GI symptoms: abdominal pain, nausea, vomiting, GI-bleeding, bloating, flatulence, constipation, diarrhea, steatorrhea, Chronic Inflammatory bowel disease, IBS (Irritable bowel syndrome), meteorism/tympanites (excessive flatulence), issues with oro-cecal transit time (slow or fast digestion), and intolerances/malabsorption to certain foods.
Indications of non-GI symptoms: muscle wasting, retardation of growth in children, weight loss, fatigue, dizziness, headaches, pale skin, a fast or irregular heartbeat, shortness of breath, chest pain, cognitive problems, cold hands and feet, fever.
Disorders suspected by physician: Crohn’s disease, cirrhosis of the liver, pancreatic insufficiency, ileocecal reflux, backwash ileitis, and anemia (due to malabsorption or Crohn’s disease).
Frequently Asked Questions
The purpose of the Hydrogen Breath Test (HBT) is to investigateunexplained gastrointestinal complaints that the patient is experiencing, such as bloating, gas, diarrhea,IBS, abdominal distention and pain, malnutrition, etc.
Using just a breath sample, this non-invasive test can help to determine if a patient has an intolerance to specific foods, detect and monitor celiac disease, as well as investigate a condition known as bacterial overgrowth.
It’s very simple. When a patient has a problem digesting certain foods (or they have bacterial overgrowth), specific bacteria in their gut get exposed to the undigested food and create the gases, hydrogen (H2) and/or methane (CH4). These gases get absorbed into their blood, which then gets dumped into their lungs, and they breathe it out.
Breath testing, and specifically HBT, has been around for over 40 years and the medical literature is very favorable regarding the accuracy of this test. As compared to other testing modalities such as cultured biopsy, the literature has demonstrated that HBT is an equally reliable analytical method.
This test is similar to other diagnostic tests that you may order for the patient, but with the added advantage that it is non-invasive – the patient can be back at work ornormal activity the same day. As with any other test, HBT offers a view into the overall picture of the patients’ gastrointestinal health.
Yes, using CPT code 91065. If the test is performed in the office and the physician interprets the results, you can be reimbursed the Global fee. You’ll use the one code regardless of which substrate/test (i.e. lactose, fructose, glucose for SIBO, etc.) that you are performing.
There is no specific limit to the number of patients that you can test simultaneously, however, there may be a limited number that you can manage effectively at one time. Generally, six patients at one time seems to be the most manageable number for one staff member to manage.
Most of the substrates are bland tasting with some having a mild sweet taste.
Small Intestine Bacterial Overgrowth (SIBO), is a condition where a specific type of bacteria which are normally only present in the colon, overgrow into the small intestine. These bacteria should not be in the small intestine and if they are present, they will feed off of the food (carbohydrates) consumed daily and create many of the gastrointestinal problems that people experience.